{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:20:03Z","timestamp":1789172403134,"version":"build-2803163510"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"DOI":"10.1038\/s41569-026-01329-0","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:22:00Z","timestamp":1786011720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Haemolytic injury and cardiovascular disease"],"prefix":"10.1038","author":[{"given":"Mark C.","family":"Hieromnimon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna M.","family":"Hieromnimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Kristin","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Gladwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1326-5839","authenticated-orcid":false,"given":"Willard N.","family":"Applefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"1329_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-3-030-41769-7_14","volume":"94","author":"MH Ahmed","year":"2020","unstructured":"Ahmed, M. H., Ghatge, M. S. & Safo, M. K. Hemoglobin: structure, function and allostery. Subcell. Biochem. 94, 345\u2013382 (2020).","journal-title":"Subcell. Biochem."},{"key":"1329_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biom12111708","author":"IT Drvenica","year":"2022","unstructured":"Drvenica, I. T., Stancic, A. Z., Maslovaric, I. S., Trivanovic, D. I. & Ilic, V. L. Extracellular hemoglobin: modulation of cellular functions and pathophysiological effects. Biomolecules https:\/\/doi.org\/10.3390\/biom12111708 (2022).","journal-title":"Biomolecules"},{"key":"1329_CR3","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1182\/blood-2008-07-161166","volume":"112","author":"N Mohandas","year":"2008","unstructured":"Mohandas, N. & Gallagher, P. G. Red cell membrane: past, present, and future. Blood 112, 3939\u20133948 (2008).","journal-title":"Blood"},{"key":"1329_CR4","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm954","volume":"9","author":"K Cosby","year":"2003","unstructured":"Cosby, K. et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9, 1498\u20131505 (2003).","journal-title":"Nat. Med."},{"key":"1329_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/ars.2009.2799","volume":"12","author":"PW Buehler","year":"2010","unstructured":"Buehler, P. W. & D\u2019Agnillo, F. Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives. Antioxid. Redox Signal. 12, 275\u2013291 (2010).","journal-title":"Antioxid. Redox Signal."},{"key":"1329_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/713609210","volume":"38","author":"M Knutson","year":"2003","unstructured":"Knutson, M. & Wessling-Resnick, M. Iron metabolism in the reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol. 38, 61\u201388 (2003).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"1329_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMra2033982","volume":"385","author":"S Berentsen","year":"2021","unstructured":"Berentsen, S. & Barcellini, W. Autoimmune hemolytic anemias. N. Engl. J. Med. 385, 1407\u20131419 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1329_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1525-1594.1995.tb02384.x","volume":"19","author":"KK Yeleswarapu","year":"1995","unstructured":"Yeleswarapu, K. K., Antaki, J. F., Kameneva, M. V. & Rajagopal, K. R. A mathematical model for shear-induced hemolysis. Artif. Organs 19, 576\u2013582 (1995).","journal-title":"Artif. Organs"},{"key":"1329_CR9","doi-asserted-by":"publisher","first-page":"M550","DOI":"10.1097\/00002480-199609000-00047","volume":"42","author":"CM Zapanta","year":"1996","unstructured":"Zapanta, C. M. et al. In vivo observation of cavitation on prosthetic heart valves. ASAIO J. 42, M550\u2013M555 (1996).","journal-title":"ASAIO J."},{"key":"1329_CR10","first-page":"655","volume":"7","author":"CM Zapanta","year":"1998","unstructured":"Zapanta, C. M., Stinebring, D. R., Deutsch, S., Geselowitz, D. B. & Tarbell, J. M. A comparison of the cavitation potential of prosthetic heart valves based on valve closing dynamics. J. Heart Valve Dis. 7, 655\u2013667 (1998).","journal-title":"J. Heart Valve Dis."},{"key":"1329_CR11","doi-asserted-by":"publisher","DOI":"10.1098\/rsfs.2015.0022","volume":"5","author":"CE Brennen","year":"2015","unstructured":"Brennen, C. E. Cavitation in medicine. Interface Focus 5, 20150022 (2015).","journal-title":"Interface Focus"},{"key":"1329_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mvr.2006.02.006","volume":"71","author":"JH Jeong","year":"2006","unstructured":"Jeong, J. H., Sugii, Y., Minamiyama, M. & Okamoto, K. Measurement of RBC deformation and velocity in capillaries in vivo. Microvasc. Res. 71, 212\u2013217 (2006).","journal-title":"Microvasc. Res."},{"key":"1329_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2023.03.001","volume":"37","author":"AP McNamee","year":"2023","unstructured":"McNamee, A. P. & Simmonds, M. J. Red blood cell sublethal damage: hemocompatibility is not the absence of hemolysis. Transfus. Med. Rev. 37, 150723 (2023).","journal-title":"Transfus. Med. Rev."},{"key":"1329_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0006-3495(72)86085-5","volume":"12","author":"LB Leverett","year":"1972","unstructured":"Leverett, L. B., Hellums, J. D., Alfrey, C. P. & Lynch, E. C. Red blood cell damage by shear stress. Biophys. J. 12, 257\u2013273 (1972).","journal-title":"Biophys. J."},{"key":"1329_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1046\/j.1525-1594.2003.07103.x","volume":"27","author":"R Paul","year":"2003","unstructured":"Paul, R. et al. Shear stress related blood damage in laminar couette flow. Artif. Organs 27, 517\u2013529 (2003).","journal-title":"Artif. Organs"},{"key":"1329_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1525-1594.2011.01243.x","volume":"35","author":"T Zhang","year":"2011","unstructured":"Zhang, T. et al. Study of flow-induced hemolysis using novel Couette-type blood-shearing devices. Artif. Organs 35, 1180\u20131186 (2011).","journal-title":"Artif. Organs"},{"key":"1329_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1161\/01.RES.41.1.2","volume":"41","author":"SP Sutera","year":"1977","unstructured":"Sutera, S. P. Flow-induced trauma to blood cells. Circ. Res. 41, 2\u20138 (1977).","journal-title":"Circ. Res."},{"key":"1329_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-3495(75)85787-0","volume":"15","author":"SP Sutera","year":"1975","unstructured":"Sutera, S. P. & Mehrjardi, M. H. Deformation and fragmentation of human red blood cells in turbulent shear flow. Biophys. J. 15, 1\u201310 (1975).","journal-title":"Biophys. J."},{"key":"1329_CR19","first-page":"237","volume":"53","author":"MJ Simmonds","year":"2016","unstructured":"Simmonds, M. J. & Meiselman, H. J. Prediction of the level and duration of shear stress exposure that induces subhemolytic damage to erythrocytes. Biorheology 53, 237\u2013249 (2016).","journal-title":"Biorheology"},{"key":"1329_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/aor.12890","volume":"41","author":"JT Horobin","year":"2017","unstructured":"Horobin, J. T., Sabapathy, S. & Simmonds, M. J. Repetitive supra-physiological shear stress impairs red blood cell deformability and induces hemolysis. Artif. Organs 41, 1017\u20131025 (2017).","journal-title":"Artif. Organs"},{"key":"1329_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1021\/acsomega.2c06768","volume":"8","author":"MN Moller","year":"2023","unstructured":"Moller, M. N. et al. Oxidants and antioxidants in the redox biochemistry of human red blood cells. ACS Omega 8, 147\u2013168 (2023).","journal-title":"ACS Omega"},{"key":"1329_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1085\/jgp.42.1.83","volume":"42","author":"E Carlsen","year":"1958","unstructured":"Carlsen, E. & Comroe, J. H. Jr. The rate of uptake of carbon monoxide and of nitric oxide by normal human erythrocytes and experimentally produced spherocytes. J. Gen. Physiol. 42, 83\u2013107 (1958).","journal-title":"J. Gen. Physiol."},{"key":"1329_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/01.ATV.0000204350.44226.9a","volume":"26","author":"DB Kim-Shapiro","year":"2006","unstructured":"Kim-Shapiro, D. B., Schechter, A. N. & Gladwin, M. T. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler. Thromb. Vasc. Biol. 26, 697\u2013705 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1329_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCULATIONAHA.110.008698","volume":"124","author":"C Donadee","year":"2011","unstructured":"Donadee, C. et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 124, 465\u2013476 (2011).","journal-title":"Circulation"},{"key":"1329_CR25","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1111\/trf.12162","volume":"53","author":"D Wang","year":"2013","unstructured":"Wang, D. et al. In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines. Transfusion 53, 3149\u20133163 (2013).","journal-title":"Transfusion"},{"key":"1329_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2013.04.028","volume":"61","author":"C Helms","year":"2013","unstructured":"Helms, C. & Kim-Shapiro, D. B. Hemoglobin-mediated nitric oxide signaling. Free Radic. Biol. Med. 61, 464\u2013472 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"1329_CR27","doi-asserted-by":"publisher","first-page":"18709","DOI":"10.1074\/jbc.273.30.18709","volume":"273","author":"X Liu","year":"1998","unstructured":"Liu, X. et al. Diffusion-limited reaction of free nitric oxide with erythrocytes. J. Biol. Chem. 273, 18709\u201318713 (1998).","journal-title":"J. Biol. Chem."},{"key":"1329_CR28","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.freeradbiomed.2006.08.017","volume":"41","author":"A Jeffers","year":"2006","unstructured":"Jeffers, A., Gladwin, M. T. & Kim-Shapiro, D. B. Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic. Biol. Med. 41, 1557\u20131565 (2006).","journal-title":"Free Radic. Biol. Med."},{"key":"1329_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nm1202-799","volume":"8","author":"CD Reiter","year":"2002","unstructured":"Reiter, C. D. et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8, 1383\u20131389 (2002).","journal-title":"Nat. Med."},{"key":"1329_CR30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","volume":"121","author":"DJ Schaer","year":"2013","unstructured":"Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D. & Vercellotti, G. M. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 121, 1276\u20131284 (2013).","journal-title":"Blood"},{"key":"1329_CR31","doi-asserted-by":"publisher","first-page":"29582","DOI":"10.1074\/jbc.M109.045344","volume":"284","author":"G Silva","year":"2009","unstructured":"Silva, G. et al. Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J. Biol. Chem. 284, 29582\u201329595 (2009).","journal-title":"J. Biol. Chem."},{"key":"1329_CR32","first-page":"500","volume":"5","author":"JM Rifkind","year":"2014","unstructured":"Rifkind, J. M., Mohanty, J. G. & Nagababu, E. The pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions. Front. Physiol. 5, 500 (2014).","journal-title":"Front. Physiol."},{"key":"1329_CR33","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1089\/ars.2007.1787","volume":"9","author":"J Balla","year":"2007","unstructured":"Balla, J. et al. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid. Redox Signal. 9, 2119\u20132137 (2007).","journal-title":"Antioxid. Redox Signal."},{"key":"1329_CR34","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1161\/CIRCRESAHA.116.306588","volume":"118","author":"LE Otterbein","year":"2016","unstructured":"Otterbein, L. E., Foresti, R. & Motterlini, R. Heme oxygenase-1 and carbon monoxide in the heart: the balancing act between danger signaling and pro-survival. Circ. Res. 118, 1940\u20131959 (2016).","journal-title":"Circ. Res."},{"key":"1329_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1113\/jphysiol.1957.sp005777","volume":"136","author":"QH Gibson","year":"1957","unstructured":"Gibson, Q. H. & Roughton, F. J. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J. Physiol. 136, 507\u2013524 (1957).","journal-title":"J. Physiol."},{"key":"1329_CR36","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1056\/NEJMoa035477","volume":"350","author":"MT Gladwin","year":"2004","unstructured":"Gladwin, M. T. et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. 350, 886\u2013895 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1329_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/rccm.201510-2058OC","volume":"193","author":"CA Schaer","year":"2016","unstructured":"Schaer, C. A. et al. Haptoglobin preserves vascular nitric oxide signaling during hemolysis. Am. J. Respir. Crit. Care Med. 193, 1111\u20131122 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1329_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1067\/mlc.2000.106458","volume":"135","author":"B Matheson","year":"2000","unstructured":"Matheson, B., Razynska, A., Kwansa, H. & Bucci, E. Appearance of dissociable and cross-linked hemoglobins in the renal hilar lymph. J. Lab. Clin. Med. 135, 459\u2013464 (2000).","journal-title":"J. Lab. Clin. Med."},{"key":"1329_CR39","first-page":"151","volume":"113","author":"WK Bleeker","year":"1989","unstructured":"Bleeker, W. K. et al. In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5\u2019-phosphate. J. Lab. Clin. Med. 113, 151\u2013161 (1989).","journal-title":"J. Lab. Clin. Med."},{"key":"1329_CR40","first-page":"115","volume":"117","author":"BK Urbaitis","year":"1991","unstructured":"Urbaitis, B. K., Razynska, A., Corteza, Q., Fronticelli, C. & Bucci, E. Intravascular retention and renal handling of purified natural and intramolecularly cross-linked hemoglobins. J. Lab. Clin. Med. 117, 115\u2013121 (1991).","journal-title":"J. Lab. Clin. Med."},{"key":"1329_CR41","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1161\/01.ATV.11.6.1700","volume":"11","author":"G Balla","year":"1991","unstructured":"Balla, G., Jacob, H. S., Eaton, J. W., Belcher, J. D. & Vercellotti, G. M. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler. Thromb. 11, 1700\u20131711 (1991).","journal-title":"Arterioscler. Thromb."},{"key":"1329_CR42","doi-asserted-by":"publisher","first-page":"20221","DOI":"10.1074\/jbc.M610737200","volume":"282","author":"RT Figueiredo","year":"2007","unstructured":"Figueiredo, R. T. et al. Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282, 20221\u201320229 (2007).","journal-title":"J. Biol. Chem."},{"key":"1329_CR43","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1172\/JCI64578","volume":"123","author":"S Ghosh","year":"2013","unstructured":"Ghosh, S. et al. Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J. Clin. Invest. 123, 4809\u20134820 (2013).","journal-title":"J. Clin. Invest."},{"key":"1329_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146416","author":"S Otsuki","year":"2021","unstructured":"Otsuki, S. et al. Monocyte-released HERV-K dUTPase engages TLR4 and MCAM causing endothelial mesenchymal transition. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.146416 (2021).","journal-title":"JCI Insight"},{"key":"1329_CR45","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1182\/blood.2021014552","volume":"140","author":"R Vats","year":"2022","unstructured":"Vats, R. et al. Liver-to-lung microembolic NETs promote gasdermin D-dependent inflammatory lung injury in sickle cell disease. Blood 140, 1020\u20131037 (2022).","journal-title":"Blood"},{"key":"1329_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89761","volume":"2","author":"MF Bennewitz","year":"2017","unstructured":"Bennewitz, M. F. et al. Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli. JCI Insight 2, e89761 (2017).","journal-title":"JCI Insight"},{"key":"1329_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1164\/rccm.201807-1370OC","volume":"201","author":"R Vats","year":"2020","unstructured":"Vats, R. et al. Platelet extracellular vesicles drive inflammasome-IL-1\u03b2-dependent lung injury in sickle cell disease. Am. J. Respir. Crit. Care Med. 201, 33\u201346 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1329_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ebiom.2015.01.003","volume":"2","author":"SK Lee","year":"2015","unstructured":"Lee, S. K., Goh, S. Y., Wong, Y. Q. & Ding, J. L. Response of neutrophils to extracellular haemoglobin and LTA in human blood system. eBioMedicine 2, 225\u2013233 (2015).","journal-title":"eBioMedicine"},{"key":"1329_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7020041","author":"J Sharma","year":"2019","unstructured":"Sharma, J. et al. Reporter cell assessment of TLR4-induced NF-\u03baB responses to cell-free hemoglobin and the influence of biliverdin. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines7020041 (2019).","journal-title":"Biomedicines"},{"key":"1329_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.561917","volume":"11","author":"OT Gbotosho","year":"2020","unstructured":"Gbotosho, O. T., Kapetanaki, M. G. & Kato, G. J. The worst things in life are free: the role of free heme in sickle cell disease. Front. Immunol. 11, 561917 (2020).","journal-title":"Front. Immunol."},{"key":"1329_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094763","author":"J Gonzales","year":"2022","unstructured":"Gonzales, J. et al. Hemin-induced endothelial dysfunction and endothelial to mesenchymal transition in the pathogenesis of pulmonary hypertension due to chronic hemolysis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23094763 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1329_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195975","author":"S Mubeen","year":"2022","unstructured":"Mubeen, S. et al. Exploring the complex network of heme-triggered effects on the blood coagulation system. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm11195975 (2022).","journal-title":"J. Clin. Med."},{"key":"1329_CR53","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1182\/bloodadvances.2020001698","volume":"5","author":"S Oishi","year":"2021","unstructured":"Oishi, S. et al. Heme activates platelets and exacerbates rhabdomyolysis-induced acute kidney injury via CLEC-2 and GPVI\/FcR\u03b3. Blood Adv. 5, 2017\u20132026 (2021).","journal-title":"Blood Adv."},{"key":"1329_CR54","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3324\/haematol.2020.246488","volume":"106","author":"JH Bourne","year":"2021","unstructured":"Bourne, J. H. et al. Heme induces human and mouse platelet activation through C-type-lectin-like receptor-2. Haematologica 106, 626\u2013629 (2021).","journal-title":"Haematologica"},{"key":"1329_CR55","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.jtha.2024.04.008","volume":"22","author":"JH Bourne","year":"2024","unstructured":"Bourne, J. H. et al. Hydroxychloroquine inhibits hemolysis-induced arterial thrombosis ex vivo and improves lung perfusion in hemin-treated mice. J. Thromb. Haemost. 22, 2018\u20132026 (2024).","journal-title":"J. Thromb. Haemost."},{"key":"1329_CR56","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3324\/haematol.2015.132183","volume":"100","author":"R Singhal","year":"2015","unstructured":"Singhal, R. et al. Hemoglobin interaction with GP1b\u03b1 induces platelet activation and apoptosis: a novel mechanism associated with intravascular hemolysis. Haematologica 100, 1526\u20131533 (2015).","journal-title":"Haematologica"},{"key":"1329_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2024.2383642","volume":"35","author":"M Zhao","year":"2024","unstructured":"Zhao, M. et al. Hemin regulates platelet clearance in hemolytic disease by binding to GPIb\u03b1. Platelets 35, 2383642 (2024).","journal-title":"Platelets"},{"key":"1329_CR58","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1111\/febs.17294","volume":"291","author":"Z Laspa","year":"2024","unstructured":"Laspa, Z. et al. Hemin-induced platelet activation is regulated by the ACKR3 chemokine surface receptor and has implications for passivation of vulnerable atherosclerotic plaques. FEBS J. 291, 5420\u20135434 (2024).","journal-title":"FEBS J."},{"key":"1329_CR59","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","volume":"110","author":"J Villagra","year":"2007","unstructured":"Villagra, J. et al. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 110, 2166\u20132172 (2007).","journal-title":"Blood"},{"key":"1329_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139437","author":"T Brzoska","year":"2020","unstructured":"Brzoska, T. et al. Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in precapillary pulmonary arterioles. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.139437 (2020).","journal-title":"JCI Insight"},{"key":"1329_CR61","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1006\/bbrc.2000.4167","volume":"280","author":"G Lin","year":"2001","unstructured":"Lin, G. et al. Hemoglobin increases endothelin-1 in endothelial cells by decreasing nitric oxide. Biochem. Biophys. Res. Commun. 280, 824\u2013830 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1329_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1172\/JCI118074","volume":"96","author":"R De Caterina","year":"1995","unstructured":"De Caterina, R. et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96, 60\u201368 (1995).","journal-title":"J. Clin. Invest."},{"key":"1329_CR63","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1182\/blood-2015-05-648030","volume":"126","author":"Q Da","year":"2015","unstructured":"Da, Q. et al. Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices. Blood 126, 2338\u20132341 (2015).","journal-title":"Blood"},{"key":"1329_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.834527","volume":"12","author":"R Sesti-Costa","year":"2021","unstructured":"Sesti-Costa, R., Silva-Filho, J. L., Barcellini, W., Le Van Kim, C. & Conran, N. Editorial: inflammatory mechanisms of hemolytic diseases. Front. Immunol. 12, 834527 (2021).","journal-title":"Front. Immunol."},{"key":"1329_CR65","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3324\/haematol.2019.239343","volume":"105","author":"N Conran","year":"2020","unstructured":"Conran, N. & De Paula, E. V. Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance. Haematologica 105, 2380\u20132390 (2020).","journal-title":"Haematologica"},{"key":"1329_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010039","author":"SK Chiang","year":"2018","unstructured":"Chiang, S. K., Chen, S. E. & Chang, L. C. A dual role of heme oxygenase-1 in cancer cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20010039 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"1329_CR67","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1523\/JNEUROSCI.0923-20.2021","volume":"42","author":"M Zille","year":"2022","unstructured":"Zille, M. et al. Hemin-induced death models hemorrhagic stroke and is a variant of classical neuronal ferroptosis. J. Neurosci. 42, 2065\u20132079 (2022).","journal-title":"J. Neurosci."},{"key":"1329_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70609","volume":"29","author":"Y Sun","year":"2025","unstructured":"Sun, Y. et al. Erk1\/2 orchestrates SSPH I-induced oxidative stress, mitochondrial dysfunction and ferroptosis in hepatocellular carcinoma. J. Cell. Mol. Med. 29, e70609 (2025).","journal-title":"J. Cell. Mol. Med."},{"key":"1329_CR69","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.bbadis.2019.05.009","volume":"1865","author":"SK NaveenKumar","year":"2019","unstructured":"NaveenKumar, S. K., Hemshekhar, M., Kemparaju, K. & Girish, K. S. Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: protection by melatonin. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 2303\u20132316 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1329_CR70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fimmu.2017.00073","volume":"8","author":"TRL Klei","year":"2017","unstructured":"Klei, T. R. L., Meinderts, S. M., van den Berg, T. K. & van Bruggen, R. From the cradle to the grave: the role of macrophages in erythropoiesis and erythrophagocytosis. Front. Immunol. 8, 73 (2017).","journal-title":"Front. Immunol."},{"key":"1329_CR71","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/ajh.26958","volume":"98","author":"J Osborne","year":"2023","unstructured":"Osborne, J., Sobh, M. & Trudel, G. Carbon monoxide as a clinical marker of hemolysis. Am. J. Hematol. 98, 1127\u20131159 (2023).","journal-title":"Am. J. Hematol."},{"key":"1329_CR72","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/84915","volume":"8","author":"AF McDonagh","year":"2001","unstructured":"McDonagh, A. F. Turning green to gold. Nat. Struct. Biol. 8, 198\u2013200 (2001).","journal-title":"Nat. Struct. Biol."},{"key":"1329_CR73","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fphar.2012.00047","volume":"3","author":"B Wegiel","year":"2012","unstructured":"Wegiel, B. & Otterbein, L. E. Go green: the anti-inflammatory effects of biliverdin reductase. Front. Pharmacol. 3, 47 (2012).","journal-title":"Front. Pharmacol."},{"key":"1329_CR74","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2007.11.022","volume":"199","author":"AC Bulmer","year":"2008","unstructured":"Bulmer, A. C., Blanchfield, J. T., Toth, I., Fassett, R. G. & Coombes, J. S. Improved resistance to serum oxidation in Gilbert\u2019s syndrome: a mechanism for cardiovascular protection. Atherosclerosis 199, 390\u2013396 (2008).","journal-title":"Atherosclerosis"},{"key":"1329_CR75","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1172\/JCI137282","volume":"130","author":"M Pfefferl\u00e9","year":"2020","unstructured":"Pfefferl\u00e9, M. et al. Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes. J. Clin. Invest. 130, 5576\u20135590 (2020).","journal-title":"J. Clin. Invest."},{"key":"1329_CR76","doi-asserted-by":"publisher","DOI":"10.1172\/jci137468","author":"TF Olonisakin","year":"2021","unstructured":"Olonisakin, T. F. et al. Stressed erythrophagocytosis induces immunosuppression during sepsis through heme-mediated STAT1 dysregulation. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci137468 (2021).","journal-title":"J. Clin. Invest."},{"key":"1329_CR77","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41418-022-00932-1","volume":"29","author":"F Vallelian","year":"2022","unstructured":"Vallelian, F. et al. Heme-stress activated NRF2 skews fate trajectories of bone marrow cells from dendritic cells towards red pulp-like macrophages in hemolytic anemia. Cell Death Differ. 29, 1450\u20131465 (2022).","journal-title":"Cell Death Differ."},{"key":"1329_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100851","volume":"73","author":"A di Masi","year":"2020","unstructured":"di Masi, A. et al. Haptoglobin: from hemoglobin scavenging to human health. Mol. Asp. Med. 73, 100851 (2020).","journal-title":"Mol. Asp. Med."},{"key":"1329_CR79","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1182\/blood-2009-01-198309","volume":"114","author":"MJ Nielsen","year":"2009","unstructured":"Nielsen, M. J. & Moestrup, S. K. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 114, 764\u2013771 (2009).","journal-title":"Blood"},{"key":"1329_CR80","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/35051594","volume":"409","author":"M Kristiansen","year":"2001","unstructured":"Kristiansen, M. et al. Identification of the haemoglobin scavenger receptor. Nature 409, 198\u2013201 (2001).","journal-title":"Nature"},{"key":"1329_CR81","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.1073\/pnas.252626999","volume":"99","author":"DE Baranano","year":"2002","unstructured":"Baranano, D. E., Rao, M., Ferris, C. D. & Snyder, S. H. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl Acad. Sci. USA 99, 16093\u201316098 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1329_CR82","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/A:1015957026924","volume":"234\u2013235","author":"SW Ryter","year":"2002","unstructured":"Ryter, S. W., Otterbein, L. E., Morse, D. & Choi, A. M. Heme oxygenase\/carbon monoxide signaling pathways: regulation and functional significance. Mol. Cell. Biochem. 234\u2013235, 249\u2013263 (2002).","journal-title":"Mol. Cell. Biochem."},{"key":"1329_CR83","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood-2003-08-2760","volume":"104","author":"ML Jison","year":"2004","unstructured":"Jison, M. L. et al. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104, 270\u2013280 (2004).","journal-title":"Blood"},{"key":"1329_CR84","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/104454902753759717","volume":"21","author":"E Tolosano","year":"2002","unstructured":"Tolosano, E. & Altruda, F. Hemopexin: structure, function, and regulation. DNA Cell Biol. 21, 297\u2013306 (2002).","journal-title":"DNA Cell Biol."},{"key":"1329_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11110660","author":"M Frimat","year":"2019","unstructured":"Frimat, M., Boudhabhay, I. & Roumenina, L. T. Hemolysis derived products toxicity and endothelium: model of the second hit. Toxins https:\/\/doi.org\/10.3390\/toxins11110660 (2019).","journal-title":"Toxins"},{"key":"1329_CR86","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","volume":"97","author":"A Aessopos","year":"2001","unstructured":"Aessopos, A. et al. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 97, 3411\u20133416 (2001).","journal-title":"Blood"},{"key":"1329_CR87","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<82::AID-AJH15>3.0.CO;2-B","volume":"57","author":"JE Hayag-Barin","year":"1998","unstructured":"Hayag-Barin, J. E., Smith, R. E. & Tucker, F. C. Jr. Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case report and review of the literature. Am. J. Hematol. 57, 82\u201384 (1998).","journal-title":"Am. J. Hematol."},{"key":"1329_CR88","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1378\/chest.102.2.642","volume":"102","author":"PG Heller","year":"1992","unstructured":"Heller, P. G., Grinberg, A. R., Lencioni, M., Molina, M. M. & Roncoroni, A. J. Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. Chest 102, 642\u2013643 (1992).","journal-title":"Chest"},{"key":"1329_CR89","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9343(82)90763-X","volume":"73","author":"FS Collins","year":"1982","unstructured":"Collins, F. S. & Orringer, E. P. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. Am. J. Med. 73, 814\u2013821 (1982).","journal-title":"Am. J. Med."},{"key":"1329_CR90","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","volume":"14","author":"P Sundd","year":"2019","unstructured":"Sundd, P., Gladwin, M. T. & Novelli, E. M. Pathophysiology of sickle cell disease. Annu. Rev. Pathol. 14, 263\u2013292 (2019).","journal-title":"Annu. Rev. Pathol."},{"key":"1329_CR91","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees, D. C., Williams, T. N. & Gladwin, M. T. Sickle-cell disease. Lancet 376, 2018\u20132031 (2010).","journal-title":"Lancet"},{"key":"1329_CR92","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato, G. J., Steinberg, M. H. & Gladwin, M. T. Intravascular hemolysis and the pathophysiology of sickle cell disease. J. Clin. Invest. 127, 750\u2013760 (2017).","journal-title":"J. Clin. Invest."},{"key":"1329_CR93","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","volume":"188","author":"JR Klinger","year":"2013","unstructured":"Klinger, J. R., Abman, S. H. & Gladwin, M. T. Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 188, 639\u2013646 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1329_CR94","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1005565","volume":"365","author":"F Parent","year":"2011","unstructured":"Parent, F. et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N. Engl. J. Med. 365, 44\u201353 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1329_CR95","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.111.032920","volume":"124","author":"V Sachdev","year":"2011","unstructured":"Sachdev, V. et al. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation 124, 1452\u20131460 (2011).","journal-title":"Circulation"},{"key":"1329_CR96","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3324\/haematol.2012.068965","volume":"98","author":"M Nouraie","year":"2013","unstructured":"Nouraie, M. et al. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica 98, 464\u2013472 (2013).","journal-title":"Haematologica"},{"key":"1329_CR97","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jama.294.1.81","volume":"294","author":"CR Morris","year":"2005","unstructured":"Morris, C. R. et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294, 81\u201390 (2005).","journal-title":"JAMA"},{"key":"1329_CR98","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.freeradbiomed.2017.04.003","volume":"108","author":"G Ingoglia","year":"2017","unstructured":"Ingoglia, G. et al. Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress. Free Radic. Biol. Med. 108, 452\u2013464 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"1329_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117223","volume":"540","author":"F Njoku","year":"2023","unstructured":"Njoku, F. et al. Associations of hemolysis and anemia with cardiopulmonary dysfunction in an adult sickle cell disease cohort. Clin. Chim. Acta 540, 117223 (2023).","journal-title":"Clin. Chim. Acta"},{"key":"1329_CR100","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/S0140-6736(16)00647-4","volume":"387","author":"MT Gladwin","year":"2016","unstructured":"Gladwin, M. T. Cardiovascular complications and risk of death in sickle-cell disease. Lancet 387, 2565\u20132574 (2016).","journal-title":"Lancet"},{"key":"1329_CR101","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/17434440.2022.2108319","volume":"19","author":"T Balthazar","year":"2022","unstructured":"Balthazar, T., Bennett, J. & Adriaenssens, T. Hemolysis during short-term mechanical circulatory support: from pathophysiology to diagnosis and treatment. Expert Rev. Med. Devices 19, 477\u2013488 (2022).","journal-title":"Expert Rev. Med. Devices"},{"key":"1329_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227793","volume":"15","author":"H Appelt","year":"2020","unstructured":"Appelt, H. et al. Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO)-comparison of VA- versus VV ECMO. PLoS ONE 15, e0227793 (2020).","journal-title":"PLoS ONE"},{"key":"1329_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05121-9","volume":"28","author":"C Blum","year":"2024","unstructured":"Blum, C. et al. Blood trauma in veno-venous extracorporeal membrane oxygenation: low pump pressures and low circuit resistance matter. Crit. Care 28, 330 (2024).","journal-title":"Crit. Care"},{"key":"1329_CR104","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0267659115595282","volume":"31","author":"KC Pan","year":"2016","unstructured":"Pan, K. C., McKenzie, D. P., Pellegrino, V., Murphy, D. & Butt, W. The meaning of a high plasma free haemoglobin: retrospective review of the prevalence of haemolysis and circuit thrombosis in an adult ECMO centre over 5 years. Perfusion 31, 223\u2013231 (2016).","journal-title":"Perfusion"},{"key":"1329_CR105","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcrc.2019.01.028","volume":"51","author":"M Bosma","year":"2019","unstructured":"Bosma, M. et al. Automated and cost-efficient early detection of hemolysis in patients with extracorporeal life support: use of the hemolysis-index of routine clinical chemistry platforms. J. Crit. Care 51, 29\u201333 (2019).","journal-title":"J. Crit. Care"},{"key":"1329_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112316","volume":"9","author":"M Lubnow","year":"2014","unstructured":"Lubnow, M. et al. Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange\u2013retrospective analysis of 265 cases. PLoS ONE 9, e112316 (2014).","journal-title":"PLoS ONE"},{"key":"1329_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124034","volume":"10","author":"HR Omar","year":"2015","unstructured":"Omar, H. R. et al. Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support. PLoS ONE 10, e0124034 (2015).","journal-title":"PLoS ONE"},{"key":"1329_CR108","doi-asserted-by":"publisher","first-page":"748","DOI":"10.5301\/ijao.5000356","volume":"37","author":"M Kutlesa","year":"2014","unstructured":"Kutlesa, M. et al. Extracorporeal membrane oxygenation treatment for H1N1-induced acute respiratory distress syndrome (ARDS): results of the Croatian Referral Center for Respiratory ECMO. Int. J. Artif. Organs 37, 748\u2013752 (2014).","journal-title":"Int. J. Artif. Organs"},{"key":"1329_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143527","volume":"10","author":"K Lehle","year":"2015","unstructured":"Lehle, K. et al. Technical-induced hemolysis in patients with respiratory failure supported with veno-venous ECMO - prevalence and risk factors. PLoS ONE 10, e0143527 (2015).","journal-title":"PLoS ONE"},{"key":"1329_CR110","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000007495","author":"V Bunger","year":"2025","unstructured":"Bunger, V. et al. Carboxyhemoglobin and methemoglobin as biomarkers of hemolysis and mortality in acute respiratory distress syndrome treated by veno-venous extracorporeal membrane oxygenation. Anesth. Analg. https:\/\/doi.org\/10.1213\/ANE.0000000000007495 (2025).","journal-title":"Anesth. Analg."},{"key":"1329_CR111","volume":"5","author":"A Meservey","year":"2023","unstructured":"Meservey, A. et al. U-shaped association between carboxyhemoglobin and mortality in patients with acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation. Crit. Care Explor. 5, e0957 (2023).","journal-title":"Crit. Care Explor."},{"key":"1329_CR112","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MAT.0000000000002278","volume":"71","author":"E Rezoagli","year":"2025","unstructured":"Rezoagli, E. et al. Signs of hemolysis predict mortality and ventilator associated pneumonia in severe acute respiratory distress syndrome patients undergoing veno-venous extracorporeal membrane oxygenation. ASAIO J. 71, 82\u201391 (2025).","journal-title":"ASAIO J."},{"key":"1329_CR113","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/SHK.0000000000002352","volume":"61","author":"V Bunger","year":"2024","unstructured":"Bunger, V. et al. Haptoglobin depletion during the first 7 days of veno-venous extracorporeal membrane oxygenation therapy is associated with increased mortality and adverse outcomes in patients with acute respiratory distress syndrome. Shock 61, 828\u2013835 (2024).","journal-title":"Shock"},{"key":"1329_CR114","doi-asserted-by":"publisher","DOI":"10.1177\/0391398820909843","author":"N Roberts","year":"2020","unstructured":"Roberts, N., Chandrasekaran, U., Das, S., Qi, Z. & Corbett, S. Hemolysis associated with Impella heart pump positioning: in vitro hemolysis testing and computational fluid dynamics modeling. Int. J. Artif. Organs https:\/\/doi.org\/10.1177\/0391398820909843 (2020).","journal-title":"Int. J. Artif. Organs"},{"key":"1329_CR115","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10047-020-01172-1","volume":"23","author":"M Nakamura","year":"2020","unstructured":"Nakamura, M. et al. Impact of the angle between aortic and mitral annulus on the occurrence of hemolysis during Impella support. J. Artif. Organs 23, 207\u2013213 (2020).","journal-title":"J. Artif. Organs"},{"key":"1329_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051206","author":"M Nakamura","year":"2022","unstructured":"Nakamura, M., Imamura, T., Hida, Y. & Kinugawa, K. Pulmonary artery pulsatility index and hemolysis during Impella-incorporated mechanical circulatory support. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm11051206 (2022).","journal-title":"J. Clin. Med."},{"key":"1329_CR117","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ejhf.1372","volume":"21","author":"T Imamura","year":"2019","unstructured":"Imamura, T. et al. Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events. Eur. J. Heart Fail. 21, 655\u2013662 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"1329_CR118","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.healun.2014.10.002","volume":"34","author":"JN Katz","year":"2015","unstructured":"Katz, J. N. et al. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy. J. Heart Lung Transpl. 34, 701\u2013709 (2015).","journal-title":"J. Heart Lung Transpl."},{"key":"1329_CR119","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.healun.2013.08.019","volume":"33","author":"AK Ravichandran","year":"2014","unstructured":"Ravichandran, A. K. et al. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes. J. Heart Lung Transpl. 33, 44\u201350 (2014).","journal-title":"J. Heart Lung Transpl."},{"key":"1329_CR120","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.jcin.2023.05.043","volume":"16","author":"CJ Van Edom","year":"2023","unstructured":"Van Edom, C. J. et al. Management of bleeding and hemolysis during percutaneous microaxial flow pump support: a practical approach. JACC Cardiovasc. Interv. 16, 1707\u20131720 (2023).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1329_CR121","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.healun.2013.08.021","volume":"33","author":"JA Cowger","year":"2014","unstructured":"Cowger, J. A. et al. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant. J. Heart Lung Transpl. 33, 35\u201343 (2014).","journal-title":"J. Heart Lung Transpl."},{"key":"1329_CR122","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1136\/hrt.35.8.849","volume":"35","author":"RJ Jacobson","year":"1973","unstructured":"Jacobson, R. J., Rath, C. E. & Perloff, J. K. Intravascular haemolysis and thrombocytopenia in left ventricular outflow obstruction. Br. Heart J. 35, 849\u2013854 (1973).","journal-title":"Br. Heart J."},{"key":"1329_CR123","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0022-3476(69)80102-2","volume":"75","author":"SD Ravenel","year":"1969","unstructured":"Ravenel, S. D., Johnson, J. D. & Sigler, A. T. Intravascular hemolysis associated with coarctation of the aorta. J. Pediatr. 75, 67\u201373 (1969).","journal-title":"J. Pediatr."},{"key":"1329_CR124","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0735-1097(95)00403-3","volume":"27","author":"MJ Garcia","year":"1996","unstructured":"Garcia, M. J. et al. Mechanisms of hemolysis with mitral prosthetic regurgitation. Study using transesophageal echocardiography and fluid dynamic simulation. J. Am. Coll. Cardiol. 27, 399\u2013406 (1996).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1329_CR125","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/CIRCULATIONAHA.123.064747","volume":"150","author":"C Quast","year":"2024","unstructured":"Quast, C. et al. Aortic valve stenosis causes accumulation of extracellular hemoglobin and systemic endothelial dysfunction. Circulation 150, 952\u2013965 (2024).","journal-title":"Circulation"},{"key":"1329_CR126","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0887-7963(03)00037-3","volume":"17","author":"TE Warkentin","year":"2003","unstructured":"Warkentin, T. E., Moore, J. C., Anand, S. S., Lonn, E. M. & Morgan, D. G. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Transfus. Med. Rev. 17, 272\u2013286 (2003).","journal-title":"Transfus. Med. Rev."},{"key":"1329_CR127","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/01.CIR.44.4.657","volume":"44","author":"E Eyster","year":"1971","unstructured":"Eyster, E., Rothchild, J. & Mychajliw, O. Chronic intravascular hemolysis after aortic valve replacement. Long-term study comparing different types of ball-valve prostheses. Circulation 44, 657\u2013665 (1971).","journal-title":"Circulation"},{"key":"1329_CR128","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.athoracsur.2005.09.045","volume":"81","author":"M Josa","year":"2006","unstructured":"Josa, M. et al. Hemolysis in mechanical bileaflet prostheses: experience with the Bicarbon valve. Ann. Thorac. Surg. 81, 1291\u20131296 (2006).","journal-title":"Ann. Thorac. Surg."},{"key":"1329_CR129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.athoracsur.2006.08.010","volume":"83","author":"GM Palatianos","year":"2007","unstructured":"Palatianos, G. M. et al. Multicentered European study on safety and effectiveness of the On-X prosthetic heart valve: intermediate follow-up. Ann. Thorac. Surg. 83, 40\u201346 (2007).","journal-title":"Ann. Thorac. Surg."},{"key":"1329_CR130","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.amjcard.2017.09.023","volume":"121","author":"TY Ko","year":"2018","unstructured":"Ko, T. Y. et al. Frequency and significance of intravascular hemolysis before and after transcatheter aortic valve implantation in patients with severe aortic stenosis. Am. J. Cardiol. 121, 69\u201372 (2018).","journal-title":"Am. J. Cardiol."},{"key":"1329_CR131","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.amjcard.2015.02.059","volume":"115","author":"J Laflamme","year":"2015","unstructured":"Laflamme, J. et al. Incidence and risk factors of hemolysis after transcatheter aortic valve implantation with a balloon-expandable valve. Am. J. Cardiol. 115, 1574\u20131579 (2015).","journal-title":"Am. J. Cardiol."},{"key":"1329_CR132","first-page":"1230","volume":"95","author":"H Yokoyama","year":"2020","unstructured":"Yokoyama, H., Mizuno, S. & Saito, S. Subacute hemolytic anemia after transcatheter edge-to-edge mitral valve repair: a case report. Catheter. Cardiovasc. Interv. 95, 1230\u20131234 (2020).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"1329_CR133","first-page":"776","volume":"98","author":"B El-Sabawi","year":"2021","unstructured":"El-Sabawi, B. et al. Hemolysis after transcatheter mitral valve replacement in degenerated bioprostheses, annuloplasty rings, and mitral annular calcification: incidence, patient characteristics, and clinical outcomes. Catheter. Cardiovasc. Interv. 98, 776\u2013785 (2021).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"1329_CR134","doi-asserted-by":"publisher","first-page":"18916","DOI":"10.1074\/jbc.274.27.18916","volume":"274","author":"O Ziouzenkova","year":"1999","unstructured":"Ziouzenkova, O. et al. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis. J. Biol. Chem. 274, 18916\u201318924 (1999).","journal-title":"J. Biol. Chem."},{"key":"1329_CR135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198901053200122","volume":"320","author":"D Steinberg","year":"1989","unstructured":"Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. & Witztum, J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915\u2013924 (1989).","journal-title":"N. Engl. J. Med."},{"key":"1329_CR136","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0021-9150(01)00422-1","volume":"158","author":"AZ Fernandez","year":"2001","unstructured":"Fernandez, A. Z. et al. Intravascular hemolysis increases atherogenicity of diet-induced hypercholesterolemia in rabbits in spite of heme oxygenase-1 gene and protein induction. Atherosclerosis 158, 103\u2013111 (2001).","journal-title":"Atherosclerosis"},{"key":"1329_CR137","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1515\/cclm-2023-0114","volume":"61","author":"C Gils","year":"2023","unstructured":"Gils, C., Hansen, D. L., Nybo, M. & Frederiksen, H. Elevated hemolysis index is associated with higher risk of cardiovascular diseases. Clin. Chem. Lab. Med. 61, 1497\u20131505 (2023).","journal-title":"Clin. Chem. Lab. Med."},{"key":"1329_CR138","doi-asserted-by":"publisher","first-page":"L765","DOI":"10.1152\/ajplung.00269.2018","volume":"315","author":"A Yalamanoglu","year":"2018","unstructured":"Yalamanoglu, A. et al. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 315, L765\u2013L774 (2018).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"1329_CR139","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1172\/JCI25040","volume":"115","author":"PC Minneci","year":"2005","unstructured":"Minneci, P. C. et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J. Clin. Invest. 115, 3409\u20133417 (2005).","journal-title":"J. Clin. Invest."},{"key":"1329_CR140","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41581-019-0181-0","volume":"15","author":"K Van Avondt","year":"2019","unstructured":"Van Avondt, K., Nur, E. & Zeerleder, S. Mechanisms of haemolysis-induced kidney injury. Nat. Rev. Nephrol. 15, 671\u2013692 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"1329_CR141","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjh.12690","volume":"164","author":"SL Saraf","year":"2014","unstructured":"Saraf, S. L. et al. Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br. J. Haematol. 164, 729\u2013739 (2014).","journal-title":"Br. J. Haematol."},{"key":"1329_CR142","doi-asserted-by":"publisher","first-page":"e1123","DOI":"10.1097\/CCM.0000000000002703","volume":"45","author":"N Kim-Campbell","year":"2017","unstructured":"Kim-Campbell, N. et al. Cell-free plasma hemoglobin and male gender are risk factors for acute kidney injury in low risk children undergoing cardiopulmonary bypass. Crit. Care Med. 45, e1123\u2013e1130 (2017).","journal-title":"Crit. Care Med."},{"key":"1329_CR143","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","volume":"390","author":"JE Moller","year":"2024","unstructured":"Moller, J. E. et al. Microaxial flow pump or standard care in infarct-related cardiogenic shock. N. Engl. J. Med. 390, 1382\u20131393 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1329_CR144","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.amjcard.2022.06.059","volume":"181","author":"K Bhatia","year":"2022","unstructured":"Bhatia, K. et al. Meta-analysis comparing venoarterial extracorporeal membrane oxygenation with or without Impella in patients with cardiogenic shock. Am. J. Cardiol. 181, 94\u2013101 (2022).","journal-title":"Am. J. Cardiol."},{"key":"1329_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03894-5","volume":"26","author":"JA Graw","year":"2022","unstructured":"Graw, J. A. et al. The role of cell-free hemoglobin and haptoglobin in acute kidney injury in critically ill adults with ARDS and therapy with VV ECMO. Crit. Care 26, 50 (2022).","journal-title":"Crit. Care"},{"key":"1329_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/cc11425","volume":"16","author":"M Adamzik","year":"2012","unstructured":"Adamzik, M. et al. Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome. Crit. Care 16, R125 (2012).","journal-title":"Crit. Care"},{"key":"1329_CR147","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/CCM.0b013e3182741a54","volume":"41","author":"DR Janz","year":"2013","unstructured":"Janz, D. R. et al. Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit. Care Med. 41, 784\u2013790 (2013).","journal-title":"Crit. Care Med."},{"key":"1329_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29558-5","volume":"8","author":"P Ekregbesi","year":"2018","unstructured":"Ekregbesi, P., Shankar-Hari, M., Bottomley, C., Riley, E. M. & Mooney, J. P. Relationship between anaemia, haemolysis, inflammation and haem oxygenase-1 at admission with sepsis: a pilot study. Sci. Rep. 8, 11198 (2018).","journal-title":"Sci. Rep."},{"key":"1329_CR149","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1182\/blood-2011-08-375303","volume":"119","author":"GB Fortes","year":"2012","unstructured":"Fortes, G. B. et al. Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood 119, 2368\u20132375 (2012).","journal-title":"Blood"},{"key":"1329_CR150","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4310816","volume":"2018","author":"J Erdei","year":"2018","unstructured":"Erdei, J. et al. Induction of NLRP3 inflammasome activation by heme in human endothelial cells. Oxid. Med. Cell. Longev. 2018, 4310816 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1329_CR151","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ni.3590","volume":"17","author":"R Martins","year":"2016","unstructured":"Martins, R. et al. Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions. Nat. Immunol. 17, 1361\u20131372 (2016).","journal-title":"Nat. Immunol."},{"key":"1329_CR152","doi-asserted-by":"publisher","first-page":"H2385","DOI":"10.1152\/ajpheart.00092.2021","volume":"320","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Mechanistic insights into cell-free hemoglobin-induced injury during septic shock. Am. J. Physiol. Heart Circ. Physiol. 320, H2385\u2013H2400 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1329_CR153","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MAT.0000000000000974","volume":"66","author":"N Dufour","year":"2020","unstructured":"Dufour, N., Radjou, A. & Thuong, M. Hemolysis and plasma free hemoglobin during extracorporeal membrane oxygenation support: from clinical implications to laboratory details. ASAIO J. 66, 239\u2013246 (2020).","journal-title":"ASAIO J."},{"key":"1329_CR154","unstructured":"Extracorporeal Life Support Organization (ELSO). General Guidelines for All ECLS Cases, Version 1.4 https:\/\/www.elso.org\/portals\/0\/elso%20guidelines%20general%20all%20ecls%20version%201_4.pdf (Extracorporeal Life Support Organization, 2017)."},{"key":"1329_CR155","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.healun.2020.03.010","volume":"39","author":"RL Kormos","year":"2020","unstructured":"Kormos, R. L. et al. Updated definitions of adverse events for trials and registries of mechanical circulatory support: a consensus statement of the mechanical circulatory support academic research consortium. J. Heart Lung Transpl. 39, 735\u2013750 (2020).","journal-title":"J. Heart Lung Transpl."},{"key":"1329_CR156","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0002-9149(93)90516-F","volume":"71","author":"J Skoularigis","year":"1993","unstructured":"Skoularigis, J., Essop, M. R., Skudicky, D., Middlemost, S. J. & Sareli, P. Frequency and severity of intravascular hemolysis after left-sided cardiac valve replacement with Medtronic Hall and St. Jude Medical prostheses, and influence of prosthetic type, position, size and number. Am. J. Cardiol. 71, 587\u2013591 (1993).","journal-title":"Am. J. Cardiol."},{"key":"1329_CR157","unstructured":"Horstkotte, D. Heart Valve Consultant (ICR Publishers, 1991)."},{"key":"1329_CR158","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.redox.2016.08.003","volume":"9","author":"JY Oh","year":"2016","unstructured":"Oh, J. Y. et al. Absorbance and redox based approaches for measuring free heme and free hemoglobin in biological matrices. Redox Biol. 9, 167\u2013177 (2016).","journal-title":"Redox Biol."},{"key":"1329_CR159","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5858\/2006-130-181-IOBCLO","volume":"130","author":"G Lippi","year":"2006","unstructured":"Lippi, G., Montagnana, M., Salvagno, G. L. & Guidi, G. C. Interference of blood cell lysis on routine coagulation testing. Arch. Pathol. Lab. Med. 130, 181\u2013184 (2006).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1329_CR160","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/vox.13543","volume":"118","author":"N Watanabe-Okochi","year":"2023","unstructured":"Watanabe-Okochi, N. et al. A novel reagent for the screening of haptoglobin-deficient blood donors. Vox Sang. 118, 1109\u20131114 (2023).","journal-title":"Vox Sang."},{"key":"1329_CR161","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1213\/ANE.0000000000002093","volume":"124","author":"K Kubota","year":"2017","unstructured":"Kubota, K., Egi, M. & Mizobuchi, S. Haptoglobin administration in cardiovascular surgery patients: its association with the risk of postoperative acute kidney injury. Anesth. Analg. 124, 1771\u20131776 (2017).","journal-title":"Anesth. Analg."},{"key":"1329_CR162","first-page":"851","volume":"53","author":"L Baldetti","year":"2024","unstructured":"Baldetti, L. et al. Haptoglobin administration for intravascular hemolysis: a systematic review. Blood Purif. 53, 851\u2013859 (2024).","journal-title":"Blood Purif."},{"key":"1329_CR163","first-page":"53","volume":"108","author":"AM Shojania","year":"1964","unstructured":"Shojania, A. M. & Gross, S. Hemolytic anemias and folic acid deficiency in children. Am. J. Dis. Child. 108, 53\u201361 (1964).","journal-title":"Am. J. Dis. Child."},{"key":"1329_CR164","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1096-8652(200103)66:3<224::AID-AJH1049>3.0.CO;2-E","volume":"66","author":"S Hirawat","year":"2001","unstructured":"Hirawat, S., Lichtman, S. M. & Allen, S. L. Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment. Am. J. Hematol. 66, 224\u2013226 (2001).","journal-title":"Am. J. Hematol."},{"key":"1329_CR165","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1378\/chest.102.1.315","volume":"102","author":"R Kornowski","year":"1992","unstructured":"Kornowski, R. et al. Erythropoietin therapy obviates the need for recurrent transfusions in a patient with severe hemolysis due to prosthetic valves. Chest 102, 315\u2013316 (1992).","journal-title":"Chest"},{"key":"1329_CR166","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jchf.2014.08.005","volume":"3","author":"ME Nassif","year":"2015","unstructured":"Nassif, M. E. et al. Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device. JACC Heart Fail. 3, 146\u2013153 (2015).","journal-title":"JACC Heart Fail."},{"key":"1329_CR167","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0002-8703(77)80311-6","volume":"93","author":"JT Santinga","year":"1977","unstructured":"Santinga, J. T., Flora, J. D., Rush, J. B., Penner, J. A. & Willis, P. W. The effect of propranolol on hemolysis in patients with an aortic prosthetic valve. Am. Heart J. 93, 197\u2013201 (1977).","journal-title":"Am. Heart J."},{"key":"1329_CR168","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/021849230701500518","volume":"15","author":"S Aoyagi","year":"2007","unstructured":"Aoyagi, S. et al. Benefits of a beta-blocker for intractable hemolysis due to paraprosthetic leakage. Asian Cardiovasc. Thorac. Ann. 15, 441\u2013443 (2007).","journal-title":"Asian Cardiovasc. Thorac. Ann."},{"key":"1329_CR169","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/0003-4975(91)91301-B","volume":"52","author":"Y Okita","year":"1991","unstructured":"Okita, Y. et al. Propranolol for intractable hemolysis after open heart operation. Ann. Thorac. Surg. 52, 1158\u20131160 (1991).","journal-title":"Ann. Thorac. Surg."},{"key":"1329_CR170","first-page":"173","volume":"48","author":"S Geller","year":"1999","unstructured":"Geller, S. & Gelber, R. Pentoxifylline treatment for microangiopathic hemolytic anemia caused by mechanical heart valves. Md. Med. J. 48, 173 (1999).","journal-title":"Md. Med. J."},{"key":"1329_CR171","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/MAT.0b013e31829f0eb1","volume":"59","author":"DL Jennings","year":"2013","unstructured":"Jennings, D. L., Williams, C. T. & Morgan, J. A. Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support. ASAIO J. 59, 526\u2013527 (2013).","journal-title":"ASAIO J."},{"key":"1329_CR172","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2143\/AC.58.5.2005300","volume":"58","author":"I Golbasi","year":"2003","unstructured":"Golbasi, I. et al. The effect of pentoxifylline on haemolysis in patients with double cardiac prosthetic valves. Acta Cardiol. 58, 379\u2013383 (2003).","journal-title":"Acta Cardiol."},{"key":"1329_CR173","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1345\/aph.19397","volume":"34","author":"JT Sherer","year":"2000","unstructured":"Sherer, J. T. & Glover, P. H. Pentoxifylline for sickle-cell disease. Ann. Pharmacother. 34, 1070\u20131074 (2000).","journal-title":"Ann. Pharmacother."},{"key":"1329_CR174","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2021.08.238","volume":"175","author":"PW Buehler","year":"2021","unstructured":"Buehler, P. W. et al. Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease. Free Radic. Biol. Med. 175, 95\u2013107 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"1329_CR175","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.300088","author":"BJ Biemond","year":"2026","unstructured":"Biemond, B. J. et al. Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemia. Haematologica https:\/\/doi.org\/10.3324\/haematol.2025.300088 (2026).","journal-title":"Haematologica"},{"key":"1329_CR176","doi-asserted-by":"publisher","DOI":"10.1093\/jscdis\/yoaf013.015","author":"VR Gordeuk","year":"2025","unstructured":"Gordeuk, V. R. et al. Design of the RHEMEDY study: a phase 2\/3 safety, efficacy and pharmacokinetics study of CSL889 in adults and adolescents with sickle cell disease during vaso-occlusive crisis. J. Sickle Cell Dis. https:\/\/doi.org\/10.1093\/jscdis\/yoaf013.015 (2025).","journal-title":"J. Sickle Cell Dis."},{"key":"1329_CR177","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1164\/rccm.201710-2150OC","volume":"198","author":"C Lei","year":"2018","unstructured":"Lei, C. et al. Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Am. J. Respir. Crit. Care Med. 198, 1279\u20131287 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1329_CR178","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1164\/rccm.201806-1165ED","volume":"198","author":"T Satoh","year":"2018","unstructured":"Satoh, T., Xu, Q., Wang, L. & Gladwin, M. T. Hemolysis-mediated toxicity during cardiopulmonary bypass ameliorated by inhaled nitric oxide gas. Am. J. Respir. Crit. Care Med. 198, 1244\u20131246 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1329_CR179","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4161\/viru.19077","volume":"3","author":"M Triantafilou","year":"2012","unstructured":"Triantafilou, M. et al. Serum proteins modulate lipopolysaccharide and lipoteichoic acid-induced activation and contribute to the clinical outcome of sepsis. Virulence 3, 136\u2013145 (2012).","journal-title":"Virulence"},{"key":"1329_CR180","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1164\/rccm.202502-0353OC","volume":"211","author":"L Savale","year":"2025","unstructured":"Savale, L. et al. Cardiopulmonary hemodynamic determinants of long-term survival in sickle cell disease: insights from the ETENDARD study. Am. J. Respir. Crit. Care Med. 211, 2096\u20132104 (2025).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1329_CR181","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1164\/rccm.202509-2289ED","volume":"211","author":"MT Gladwin","year":"2025","unstructured":"Gladwin, M. T., Kato, G. J. & Machado, R. F. Ten-year longitudinal study clarifies impact of hemolysis and pulmonary hypertension on patients with sickle cell anemia. Am. J. Respir. Crit. Care Med. 211, 1990\u20131991 (2025).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1329_CR182","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.7150\/ijms.50217","volume":"18","author":"LA Materne","year":"2021","unstructured":"Materne, L. A., Hunsicker, O., Menk, M. & Graw, J. A. Hemolysis in patients with extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome - a systematic review of the literature. Int. J. Med. Sci. 18, 1730\u20131738 (2021).","journal-title":"Int. J. Med. Sci."},{"key":"1329_CR183","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1097\/MAT.0000000000001712","volume":"68","author":"I Salas de Armas","year":"2022","unstructured":"Salas de Armas, I. et al. Surgically implanted Impella device for patients on Impella CP support experiencing refractory hemolysis. ASAIO J. 68, e251\u2013e255 (2022).","journal-title":"ASAIO J."},{"key":"1329_CR184","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.299.19.jrv80007","volume":"299","author":"C Natanson","year":"2008","unstructured":"Natanson, C., Kern, S. J., Lurie, P., Banks, S. M. & Wolfe, S. M. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 299, 2304\u20132312 (2008).","journal-title":"JAMA"},{"key":"1329_CR185","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/trf.18116","volume":"65","author":"JS Jahr","year":"2025","unstructured":"Jahr, J. S., MacKinnon, K., Baum, V. C. & Alayash, A. I. Hemoglobin-based oxygen carriers: biochemical, biophysical differences, and safety. Transfusion 65, 386\u2013396 (2025).","journal-title":"Transfusion"},{"key":"1329_CR186","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nbt0798-672","volume":"16","author":"DH Doherty","year":"1998","unstructured":"Doherty, D. H. et al. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat. Biotechnol. 16, 672\u2013676 (1998).","journal-title":"Nat. Biotechnol."},{"key":"1329_CR187","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.freeradbiomed.2003.11.030","volume":"36","author":"JS Olson","year":"2004","unstructured":"Olson, J. S. et al. NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic. Biol. Med. 36, 685\u2013697 (2004).","journal-title":"Free Radic. Biol. Med."},{"key":"1329_CR188","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1152\/jappl.1993.74.4.1769","volume":"74","author":"JR Hess","year":"1993","unstructured":"Hess, J. R., MacDonald, V. W. & Brinkley, W. W. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J. Appl. Physiol. 74, 1769\u20131778 (1993).","journal-title":"J. Appl. Physiol."},{"key":"1329_CR189","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1152\/jappl.1994.77.5.2348","volume":"77","author":"A Thompson","year":"1994","unstructured":"Thompson, A., McGarry, A. E., Valeri, C. R. & Lieberthal, W. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J. Appl. Physiol. 77, 2348\u20132354 (1994).","journal-title":"J. Appl. Physiol."},{"key":"1329_CR190","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1152\/jappl.1995.79.1.236","volume":"79","author":"R Lee","year":"1995","unstructured":"Lee, R., Neya, K., Svizzero, T. A. & Vlahakes, G. J. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J. Appl. Physiol. 79, 236\u2013242 (1995).","journal-title":"J. Appl. Physiol."},{"key":"1329_CR191","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2501389122","volume":"122","author":"MR Dent","year":"2025","unstructured":"Dent, M. R. et al. Engineering a highly selective, hemoprotein-based scavenger as a carbon monoxide poisoning antidote with no hypertensive effect. Proc. Natl Acad. Sci. USA 122, e2501389122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01329-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:03:58Z","timestamp":1786017838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01329-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":191,"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1038\/s41569-026-01329-0","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"21 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}